GE Healthcare is looking to boost its life sciences portfolio with the acquisition of a cellular imaging firm.

The General Electric Co. (NYSE:GE) unit is planning to buy Seattle area Applied Precision Inc. in a bid to expand its research products and services offering for the pharmaceutical and life science industries, the company said.